ArticlePharmaceuticals (Basel, Switzerland)2022

Real-World Use of Molnupiravir in the Treatment of Outpatients with SARS-CoV-2 Infection-A Patient Profile Based on the Experience of a Tertiary Infectious Disease Center.

Anca Streinu-Cercel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.